drugset / Trial / NCT00660010

Study of Lupron Depot In The Treatment of Central Precocious Puberty

NCT00660010

Phase 3 Completed 55 enrolled Abbott
Non-randomizedSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to determine if Lupron (leuprolide acetate) is safe and effective in treating children with Central Precocious Puberty (CPP), and to assess long term effects of leuprolide acetate treatment after therapy is discontinued.

Timeline

Start
1991-01
Primary completion
2009-04
Completion
2009-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Leuprolide Other / unclassified 300 ug/kg Intramuscular